DB11452ExperimentalVet approvedSmall molecule
Ponazuril, sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.
- Formula / weight
- C18H14F3N3O6S · 457.38 g/mol (avg)
- Code names
- BAY-Vi 9143
Resolves to
Clinical / RWD
Structure
InChIKey
VBUNOIXRZNJNAD-UHFFFAOYSA-NSMILESCN1C(=O)NC(=O)N(C1=O)C1=CC=C(OC2=CC=C(C=C2)S(=O)(=O)C(F)(F)F)C(C)=C1What you can answer from here — as of March 06, 2025
Which companies are running trials of Ponazuril, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account